• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Jury convicts ex-MiMedx execs in fraud case

Jury convicts ex-MiMedx execs in fraud case

November 19, 2020 By Nancy Crotti

Two former executives of MiMedx were convicted today on charges in an alleged fraud scheme involving distributors, according to federal prosecutors.

A Manhattan jury rendered the verdicts against former CEO Parker H. “Pete” Petit and former COO William C. Taylor, whom federal prosecutors claimed had entered into undisclosed side arrangements with five distributors. These side arrangements allowed distributors to return product to MiMedx or conditioned distributors’ payment obligations on sales to end-users, the government charged.

Petit, 81, was convicted of securities fraud and Taylor, 52, was convicted of conspiracy to commit securities fraud, to make false statements in SEC filings and to mislead the conduct of audits, according to a news release from the U.S. Attorney’s Office for the Southern District of New York.

The securities fraud count carries a maximum sentence of 20 years in prison, and the conspiracy count carries a maximum sentence of five years in prison.

Federal prosecutors claimed that Petit’s and Taylor’s alleged manipulation of MiMedx’s revenue caused MiMedx to report 2015 annual revenue that was fraudulently inflated by approximately $9.5 million, or about 5%.

Nearly one year ago, MiMedx agreed to pay $1.5 million to settle federal charges that it and three former top executives allegedly defrauded investors.

The SEC alleged that from 2013 to 2017, Marietta, Ga.-based MiMedx and those executives misstated the company’s revenue and attempted to cover up their misconduct. Specifically, the SEC claimed that they prematurely recognized revenue from sales to MiMedx’s distributors and exaggerated the company’s revenue growth.

According to the SEC complaint, Petit and Taylor allegedly covered up the scheme for years, even after MiMedx’s former controller raised concerns about the company’s accounting for specific distributor transactions. The SEC also alleged that Petit and Taylor misled MiMedx’s outside auditors, members of the company’s audit committee, and outside lawyers who inquired about these transactions.

Petit and Taylor have denied the federal allegations, according to Law360, which said the defendants’ attorneys will likely appeal.

MiMedx, which makes regenerative and therapeutic biologics using human placental tissue allografts, ousted Petit and Taylor for cause after an independent probe into its revenue recognition forced MiMedx to restate its earnings going back to 2012. The investigation found that Petit and his management team enacted a scheme to cook the books, retaliating against anyone who questioned their accounting practices and secretly filming their offices.

In May 2019, MiMedx released a new “comprehensive plan” to refresh the board, in cooperation with major shareholder Prescience Point Capital Management, to include CEO Timothy Wright, Kew Group co-founder, president & CEO Kathleen Behrens Wilsey and Apollo Endosurgery (NSDQ:APEN) CEO Todd Newton. Petit then launched a proxy war, nominating himself, former Pulte Home tax director David Furstenburger and George & Lorenson partner Shawn George for board seats. The company claimed victory in that effort in June 2019.

Petit and Taylor are scheduled to be sentenced in February 2021.

This article has been updated with information from the U.S. Attorney’s Office for the Southern District of New York.

 

 

Filed Under: Business/Financial News, Featured, Legal News Tagged With: MiMedx Group Inc., Securities & Exchange Commission (SEC), U.S. Attorney

More recent news

  • EBR Systems raises $36.1M for leadless pacing tech
  • The biggest cardiovascular tech news out of EuroPCR 2025
  • CardiaWave has positive 12-month Valvosoft results
  • Elixir Medical reports sustained durability with bioadaptor compared to Medtronic stent
  • Medtronic has new Cardiovascular, CST leaders after longtime exec departs

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy